Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lou Gehrig's Disease”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Not applicableWithdrawnNCT01459302
What this trial is testing

Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal DementiaPLS+7 more
University of Massachusetts, Worcester
Not applicableStudy completedNCT03868345
What this trial is testing

Speech Analysis in ALS Patients

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig Disease
Barrow Neurological Institute 26
Not applicableLooking for participantsNCT01772602
What this trial is testing

The National Amyotrophic Lateral Sclerosis Registry

Who this might be right for
Amyotrophic Lateral Sclerosis
Centers for Disease Control and Prevention 30,000
Not applicableStudy completedNCT00809224
What this trial is testing

Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALSAmyotrophic Lateral Sclerosis
University of Michigan 92
Testing effectiveness (Phase 2)Study completedNCT00647296
What this trial is testing

Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 194
Large-scale testing (Phase 3)Study completedNCT00573443
What this trial is testing

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

Who this might be right for
Pseudobulbar Affect (PBA)
Avanir Pharmaceuticals 326
Large-scale testing (Phase 3)Study completedNCT00125203
What this trial is testing

Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisSialorrhea
The University of Texas Health Science Center at San Antonio 20
Large-scale testing (Phase 3)Study completedNCT04414345
What this trial is testing

HEALEY ALS Platform Trial - Regimen C CNM-Au8

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 161
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07688239
What this trial is testing

The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)ALS - Amyotrophic Lateral SclerosisALS
Tiziana Life Sciences LTD 44
Large-scale testing (Phase 3)Study completedNCT00444613
What this trial is testing

A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Eisai Co., Ltd. 373
Not applicableLooking for participantsNCT05067179
What this trial is testing

Analysis of Human ALS Tissues and Registry of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Illinois at Chicago 40
Not applicableNo Longer AvailableNCT06069934
What this trial is testing

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

Who this might be right for
Amyotrophic Lateral Sclerosis
Prilenia
Testing effectiveness (Phase 2)Study completedNCT02469896
What this trial is testing

A Trial of Tocilizumab in ALS Subjects

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig's Disease+1 more
Barrow Neurological Institute 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04220021
What this trial is testing

Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD

Who this might be right for
C9orf72 Amyotrophic Lateral Sclerosis (ALS)Frontotemporal Dementia
University of Florida 41
Large-scale testing (Phase 3)Study completedNCT00706147
What this trial is testing

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Miami 38
Testing effectiveness (Phase 2)Study completedNCT00956488
What this trial is testing

Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron DiseaseLou Gehrig's Disease
Wake Forest University Health Sciences 9
Not applicableStudy completedNCT00116558
What this trial is testing

Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation

Who this might be right for
Amyotrophic Lateral Sclerosis
Edward Kasaraskis 153
Early research (Phase 1)UnknownNCT00673140
What this trial is testing

Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
GAAD Medical Research Institute Inc. 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT04055623
What this trial is testing

T-regulatory Cells in ALS

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
The Methodist Hospital Research Institute 12
Early research (Phase 1)Looking for participantsNCT07401121
What this trial is testing

Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Celosia Therapeutics Pty Ltd 15
Next Page